Ukko-Peanut
Peanut allergy
PreclinicalActive
Key Facts
About Ukko
AI‑powered protein design company developing hypoallergenic immunotherapies for food allergies.
View full company profileTherapeutic Areas
Other Peanut allergy Drugs
| Drug | Company | Phase |
|---|---|---|
| PRT120 | Prota Therapeutics | Phase 3 |
| INP20 | InnoUp | Clinical |
| Food Allergy Program | Hal Allergy | Clinical Development |
| Peanut allergy program | Desentum | Unknown |
| Peanut Oral Immunotherapy | Camallergy | Phase 2 |
| INT301 (implied) | Intrommune Therapeutics | Pre-clinical |
| VLP Peanut (VLP-p) | Allergy Therapeutics | Phase II |